17:10:44 EDT Wed 06 May 2026
Enter Symbol
or Name
USA
CA



American Vanguard Reports First Quarter 2026 Results

2026-05-06 16:05 ET - News Release

First Quarter Revenue Growth of 7% to $124 million

Gross Margin Expansion of 500 bps

Reaffirm Full-Year Outlook; Adjusted EBITDA $44 million to $48 million on Sales of $530 million to $550 million

NEWPORT BEACH, CA / ACCESS Newswire / May 6, 2026 / American Vanguard Corporation, a diversified specialty and agricultural products company that develops, manufactures, and markets solutions for crop protection and nutrition, turf and ornamental management and commercial pest control, today reported financial results for the first quarter ended March 31, 2026.

Financial and Operational Highlights First Quarter 2026 - versus First Quarter 2025:

  • Net sales of $124 million vs. $116 million;

  • Gross profit margin of 31% vs. 26%;

  • Operating income of $1.9 million vs. an operating loss of $4.3 million:

  • Net loss of $4.1 million vs. $8.5 million;

  • Adjusted EBITDA1 of $10.3 million vs. $3.0 million;

  • EPS of $(0.14) vs. ($0.30);

Dak Kaye, CEO of American Vanguard, stated "American Vanguard got off to a good start in the first quarter of 2026, with Net Sales of $124 million, up approximately 7% year-over-year, driven by strong demand in our domestic crop business. Adjusted EBITDA improved significantly year-over-year, reflecting better margins, cost discipline, and the benefits of the business improvements we have been implementing. While the agricultural environment remains challenging with farmers continuing to buy on a just-in-time basis and geopolitical uncertainty adding to that caution, we are controlling what we can control and executing our plan."

Mr. Kaye concluded, "As part of our business improvement initiative, we have begun the optimization of activities at our Los Angeles manufacturing facility and are relocating synthesis operations to build on the strengths of our Axis site. The manufacturing optimization initiative is progressing as planned, and we expect annualized savings of at least $4 million. Our new capital structure, anchored by the two term loans, provides the longer-term financial foundation we need to execute our growth strategy without being constrained by seasonal working capital dynamics. Our growth strategy is focused on incremental increases in sales and margin improvement alongside balance sheet strengthening. This strategy is focused on improving our net working capital and lowering our net debt2, putting us in a position to refinance our debt by the end of 2028, if we chose to do so."

_________________________________

1Adjusted earnings before interest, taxes, depreciation, and amortization (Adjusted EBITDA) is not a financial measure calculated and presented in accordance with U.S. generally accepted accounting principles (GAAP) and should not be considered as an alternative to net (loss) income, operating (loss) income or any other financial measure so calculated and presented, nor as an alternative to cash flow from operating activities as a measure of liquidity. The items excluded from adjusted EBITDA are detailed in the reconciliation attached to this news release. Other companies (including the Company's competitors) may define adjusted EBITDA differently.

2Net debt, a non-GAAP measure, is presented as supplemental disclosure because we believe it is useful in understanding our financial condition. Net debt is calculated as total outstanding indebtedness less cash.

David Johnson, Chief Financial Officer stated, "Our first quarter financial results reflect meaningful progress across the business. Gross margin reached 31%, up 500 basis points, as compared to the year-ago period, driven by a favorable mix of higher-margin domestic crop products, strong performance in our OHP Specialty business, and continued factory efficiency. Operating expenses ended the quarter slightly lower than prior year, when expressed as a percentage of net sales, a clear reflection of our continued cost discipline."

Mr. Johnson continued, "With the refinancing, the balance sheet included cash of $71 million at quarter-end, as compared to cash of $12 million this time last year. Net debt at the end of the quarter was $196 million. Our accounts receivable increased compared to the same time last year because of the lower level of customer prepayments in December 2025, as compared to the prior year. We expect to receive those payments in June and in July, thereby further strengthening our cash position. Inventories declined by nearly $10 million year-over-year to $175 million, demonstrating that our Sales and Inventory planning process ("SIOP") improvements and supply chain discipline are gaining traction. We remain focused on lowering our net trade working capital and reducing net debt."

Earnings Conference Call
The company will be hosting an earnings conference call on May 6, 2026 at 4:30 pm Eastern Time/1:30 pm Pacific Time.

The conference call will be webcast on the Company's website at https://www.investors-american vanguard.com/ or by going to the following link: https://www.webcaster5.com/Webcast/Page/3070/53902

If you are unable to listen live, the conference call will be archived for one year and may be accessed using the company's website: https://www.investors-american-vanguard.com/

About American Vanguard
American Vanguard Corporation is a diversified specialty and agriculture products company that develops and markets products for crop protection and management, turf and ornamentals management, and public health. Over the past 20 years, through product and business acquisitions, the Company has significantly expanded its operations and now has more than 1,000 product registrations worldwide. To learn more about the Company, please reference www.american-vanguard.com.

The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release the matters set forth in this press release include forward-looking statements. These statements can be identified by the fact that they do not relate strictly to historical or current facts. Forward looking statements often use words such as "believe," "expect," "anticipate," "intend," "estimate," "project," "outlook," "forecast," "target," "trend," "plan," "goal," or other words of comparable meaning or future-tense or conditional verbs such as "may," "will," "should," "would," or "could." These forward-looking statements are based on the current expectations and estimates by the Company's management and are subject to various risks and uncertainties that may cause results to differ from management's current expectations. Such factors include risks detailed from time-to-time in the Company's SEC reports and filings. All forward-looking statements, if any, in this release represent the Company's judgment as of the date of this release. The company disclaims any intent or obligation to update these forward-looking statements.

Non-GAAP Financial Measures
In addition to providing results that are determined in accordance with accounting principles generally accepted in the United States of America (GAAP), we present Adjusted EBITDA and Net Debt, which are non-GAAP financial measures. These measures should not be considered in isolation or as an alternative to GAAP measures such as net income, or diluted earnings per share, as applicable, or other financial statement data presented in our financial statements as an indicator of our financial performance or liquidity.

We define Net Debt as outstanding indebtedness less cash and EBITDA as net (loss) income, adjusted for depreciation and amortization, provision for income taxes and interest expense. We define Adjusted EBITDA as EBITDA as further adjusted for stock compensation expense and for certain items management believe are not reflective of the underlying operations of our business, including but not limited to the exclusion of charges that are considered by management to be unusual and not representative of the Company's underlying performance and future prospects. In 2026 and 2025 that included non-recurring expenses. The resulting Adjusted EBITDA measure is aligned with the Company's metric for its credit facility agreement in the applicable periods.

We use Adjusted EBITDA to assess the operating results and effectiveness and efficiency of our business. We present this non-GAAP financial measure because we believe that investors consider Adjusted EBITDA to be an important supplemental measure of performance, and we believe that this measure is frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry. As the Company continues to work through its transformation efforts, management believes that presenting Adjusted EBITDA provides an effective comparison between the Company and its industry peers. Non-GAAP financial measures as reported by us may not be comparable to similarly titled metrics reported by other companies and may not be calculated in the same manner. These measures have limitations as analytical tools, and you should not consider them in isolation or as substitutes for analysis of our results as reported under GAAP.

The Company is not able to provide a reconciliation without unreasonable efforts of its forward-looking guidance related to adjusted EBITDA to the most directly comparable GAAP financial measure due to the inherent difficulty in predicting with reasonable certainty the timing and amount of certain items that are excluded from Adjusted EBITDA, such as share-based compensation, acquisition-related expenses, and foreign exchange gains or losses, which could be material to the Company's results computed in accordance with GAAP.

Investor Representative
Alpha IR Group
Robert Winters
Robert.winters@alpha-ir.com
(917) 821-6305

CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except share data) (Unaudited)

ASSETS

March 31,
2026

December 31,
2025

Current assets:

Cash

$

70,914

$

12,425

Receivables:

Trade, net of allowance for credit losses of $12,293 and $11,733, respectively

179,336

160,511

Other

7,372

7,278

Total receivables, net

186,708

167,789

Inventories

175,038

176,034

Prepaid expenses

7,687

9,668

Income taxes receivable

3,203

4,606

Total current assets

443,550

370,522

Property, plant and equipment, net

51,721

53,036

Operating lease right-of-use assets, net

16,031

16,793

Intangible assets, net

136,071

138,746

Deferred income tax assets

3,369

2,637

Other assets

14,501

14,803

Total assets

$

665,243

$

596,537

Liabilities and Stockholders' Equity

Current liabilities:

Current portion of long-term debt

$

2,250

$

-

Accounts payable

90,672

87,505

Customer prepayments

14,438

33,094

Accrued program costs

46,099

52,227

Accrued expenses and other payables

30,436

28,261

Operating lease liabilities, current

5,517

5,765

Income taxes payable

1,512

2,594

Total current liabilities

190,924

209,446

Long-term debt, net of current portion(2)

264,384

174,000

Operating lease liabilities, long-term

10,991

11,621

Deferred income tax liabilities

8,209

8,150

Other liabilities

1,115

923

Total liabilities

475,623

404,140

Commitments and contingent liabilities (Note 13)

Stockholders' equity:

Preferred stock, $0.10 par value per share; authorized 400,000 shares; none issued

-

-

Common stock, $0.10 par value per share; authorized 40,000,000 shares; issued 34,979,775 shares at March 31, 2026 and 34,923,562 shares at December 31, 2025

3,498

3,492

Additional paid-in capital

117,530

117,106

Accumulated other comprehensive loss

(11,062

)

(12,000

)

Retained earnings

150,855

155,000


260,821

263,598

Less treasury stock at cost, 5,915,182 shares at March 31, 2026 and December 31, 2025

(71,201

)

(71,201

)

Total stockholders' equity

189,620

192,397

Total liabilities and stockholders' equity

$

665,243

$

596,537

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)


For the three months
ended March 31


2026

2025

Net sales

$

123,568

$

115,800

Cost of sales

(85,151

)

(85,609

)

Gross profit

38,417

30,191

Operating expenses

Selling, general and administrative

(27,713

)

(26,628

)

Research, product development and regulatory

(5,271

)

(5,682

)

Product liability claims

(81

)

-

Transformation

(2,804

)

(2,191

)

Asset impairments

(659

)

-

Operating income (loss)

1,889

(4,310

)

Change in fair value of an equity investment

(120

)

-

Interest expense, net

(5,790

)

(3,765

)

Loss before provision for income taxes

(4,021

)

(8,075

)

Income tax expense

(124

)

(387

)

Net loss

$

(4,145

)

$

(8,462

)

Net loss per common share - basic

$

(0.14

)

$

(0.30

)

Net loss per common share - assuming dilution

$

(0.14

)

$

(0.30

)

Weighted average shares outstanding - basic

28,649

28,271

Weighted average shares outstanding - assuming dilution

28,649

28,271


AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES
ANALYSIS OF SALES
(In thousands)
(Unaudited)

For the three months ended
March 31,



2026

2025

Change

% Change

Net sales:

U.S. crop

$

67,028

$

57,176

$

9,852

17

%

U.S. Specialty

16,502

15,601

901

6

%

Total U.S.

83,530

72,777

10,753

15

%

International

40,038

43,023

(2,985

)

-7

%

Total net sales

$

123,568

$

115,800

$

7,768

7

%

Total cost of sales

$

(85,151

)

$

(85,609

)

$

458

-1

%

Total gross profit

$

38,417

$

30,191

$

8,226

27

%

Total gross margin

31

%

26

%

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)

For the three months
ended March 31

2026

2025

Cash flows from operating activities:

Net loss

$

(4,145

)

$

(8,462

)

Adjustments to reconcile net loss to net cash used in operating
activities:

Depreciation and amortization of property, plant and equipment and intangible assets

4,685

4,744

Amortization of other long-term assets

5

5

Provision for estimated credit losses

444

1,056

Stock-based compensation

186

559

Deferred income taxes

(204

)

1,348

Change in liabilities for uncertain tax positions or unrecognized tax benefits

(17

)

90

Change in equity investment fair value

120

-

Impairment of assets

659

-

Payment-in-Kind interest

112

-

Amortization of deferred loan fees

738

235

Lease obligations and non-cash lease expense, net

(115

)

(109

)

Foreign currency transaction (losses) gains

28

(99

)

Changes in assets and liabilities associated with operations:

(Increase) decrease in net receivables

(19,088

)

6,892

Decrease (increase) in inventories

1,530

(4,721

)

Increase in prepaid expenses and other assets

(877

)

(856

)

Change in income tax receivable and payable, net

385

(1,885

)

Increase in accounts payable

2,871

22,966

Decrease in customer prepayments

(18,656

)

(28,215

)

(Decrease) increase in accrued program costs

(6,170

)

837

Increase (decrease) in other payables and accrued expenses

2,067

(14,961

)

Net cash used in operating activities

(35,442

)

(20,576

)

Cash flows from investing activities:

Capital expenditures

(971

)

(431

)

Proceeds from disposal of property, plant and equipment

7

12

Intangible assets

(9

)

(27

)

Net cash used in investing activities

(973

)

(446

)

Cash flows from financing activities:

Payments under line of credit agreement

(140,000

)

(89,098

)

Borrowings under line of credit agreement

26,000

109,265

Borrowings under term loans

225,000

-

Payment of deferred loan fees

(16,234

)

(687

)

Net receipt from the issuance of common stock under ESPP

263

332

Net payment from common stock purchased for tax withholding

(19

)

(11

)

Net cash provided by financing activities

95,010

19,801

Net increase (decrease) in cash

58,595

(1,221

)

Effect of exchange rate changes on cash and cash equivalents

(106

)

512

Cash at beginning of period

12,425

12,514

Cash at end of period

$

70,914

$

11,805


AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES
RECONCILIATION OF NET LOSS TO ADJUSTED EBITDA
(In thousands)
(Unaudited)

For the three months
ended March 31

2026

2025

Net loss

$

(4,145

)

$

(8,462

)

Provision for income taxes

124

387

Interest expense, net

5,790

3,765

Depreciation and amortization

4,624

4,749

Stock compensation expense

186

559

Transformation costs

2,804

2,191

Asset impairments

659

-

Other

217

(216

)

Adjusted EBITDA(1)

$

10,259

$

2,973

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES
RECONCILIATION OF TOTAL INDEBTEDNESS TO NET DEBT
(In thousands)
(Unaudited)

March 31, 2026

December 31, 2025

Current portion of long-term debt

$

2,250

$

-

Long-term debt, net of current portion

264,384

174,000

Total indebtedness

$

266,634

$

174,000

Less: Cash

(70,914

)

(12,425

)

Net Debt (2)

$

195,720

$

161,575


1 Adjusted earnings before interest, taxes, depreciation, and amortization (Adjusted EBITDA) is not a financial measure calculated and presented in accordance with U.S. generally accepted accounting principles (GAAP) and should not be considered as an alternative to net (loss) income, operating (loss) income or any other financial measure so calculated and presented, nor as an alternative to cash flow from operating activities as a measure of liquidity. The items excluded from adjusted EBITDA are detailed in the reconciliation attached to this news release. Other companies (including the Company's competitors) may define adjusted EBITDA differently.

2 Net debt, a non-GAAP measure, is presented as supplemental disclosure because we believe it is useful in understanding our financial condition. Net debt is calculated as total outstanding indebtedness less cash.

SOURCE: American Vanguard



View the original press release on ACCESS Newswire

© 2026 Canjex Publishing Ltd. All rights reserved.